Back to Search
Start Over
Hyperlipidemia medication management in patients admitted for a myocardial infarction
- Source :
- Pharmacy Practice (Granada) v.9 n.1 2011, SciELO España. Revistas Científicas Españolas de Ciencias de la Salud, instname, Pharmacy Practice
- Publication Year :
- 2011
- Publisher :
- Centro de Investigaciones y Publicaciones Farmacéuticas, 2011.
-
Abstract
- Objectives: The purpose of this study is to determine the percentage of patients admitted for acute myocardial infarction currently prescribed a statin, with low-density lipoprotein (LDL) 0.2 ng/dL and lipid panel performed within 96 hours of troponin. Patients with a triglyceride level > 400 mg/dL were excluded. The residual risk population consisted of patients currently taking a statin with LDL
- Subjects :
- medicine.medical_specialty
Statin
HDL
medicine.drug_class
Population
Myocardial Infarction
Niacin
Internal medicine
Hyperlipidemia
medicine
Myocardial infarction
education
Original Research
education.field_of_study
business.industry
Incidence (epidemiology)
mesh:Niacin
medicine.disease
United States
Surgery
Residual risk
Cholesterol
mesh:HDL
mesh:Cholesterol
mesh:Myocardial Infarction
lipids (amino acids, peptides, and proteins)
mesh:United States
business
Lipoprotein
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Pharmacy Practice (Granada) v.9 n.1 2011, SciELO España. Revistas Científicas Españolas de Ciencias de la Salud, instname, Pharmacy Practice
- Accession number :
- edsair.doi.dedup.....ac5accafa9e595c7c20cbfb1d345741e